Literature DB >> 8811453

Determination of human plasma xanthine oxidase activity by high-performance liquid chromatography.

T Yamamoto1, Y Moriwaki, S Takahashi, Z Tsutsumi, J Yamakita, Y Nasako, K Hiroishi, K Higashino.   

Abstract

An assay for human plasma xanthine oxidase activity was developed with pterin as the substrate and the separation of product (isoxanthopterin) by high-performance liquid chromatography with a fluorescence detector. The reaction mixture consists of 60 microliters of plasma and 240 microliters of 0.2 M Tris-HCl buffer (pH 9.0) containing 113 microM pterin. With this assay, the activity of plasma xanthine oxidase could be easily determined despite its low activity. As a result, it could be demonstrated that the intravenous administration of heparin or the oral administration of ethanol did not increase plasma xanthine oxidase activity in normal subjects, and also that plasma xanthine oxidase activity was higher in patients with hepatitis C virus infection than in healthy subjects or patients with gout. In addition, a single patient with von Gierke's disease showed a marked increase in the plasma activity of this enzyme, relative to that apparent in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811453     DOI: 10.1016/0378-4347(96)00071-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  9 in total

1.  The role of human xanthine oxidoreductase (HXOR), anti-HXOR antibodies, and microorganisms in synovial fluid of patients with joint inflammation.

Authors:  Najah Al-Muhtaseb; Elham Al-Kaissi; Abdul Jalil Thawaini; Zuhair Muhi Eldeen; Sabah Al-Muhtaseb; Badiee Al-Saleh
Journal:  Rheumatol Int       Date:  2011-06-05       Impact factor: 2.631

2.  Biochemical measurement of neonatal hypoxia.

Authors:  Megan S Plank; Teleka C Calderon; Yayesh Asmerom; Danilo S Boskovic; Danilyn M Angeles
Journal:  J Vis Exp       Date:  2011-08-24       Impact factor: 1.355

Review 3.  Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions.

Authors:  Slobodan P Rendić; Rachel D Crouch; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2022-06-01       Impact factor: 6.168

4.  Response and recovery in the plasma metabolome tracks the acute LCMV-induced immune response.

Authors:  William R Wikoff; Ewa Kalisak; Sunia Trauger; Marianne Manchester; Gary Siuzdak
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

5.  Xanthine oxidase injurious response in acute joint injury.

Authors:  Thomas Stabler; Robert D Zura; Ming-Feng Hsueh; Virginia B Kraus
Journal:  Clin Chim Acta       Date:  2015-09-28       Impact factor: 3.786

6.  Nanohybrid electrochemical enzyme sensor for xanthine determination in fish samples.

Authors:  Nirmal Kant Sharma; Ankur Kaushal; Shikha Thakur; Neerja Thakur; Dinesh Kumar; Tek Chand Bhalla
Journal:  3 Biotech       Date:  2021-04-11       Impact factor: 2.406

7.  Simultaneous determination of uric Acid and xanthine using a poly(methylene blue) and electrochemically reduced graphene oxide composite film modified electrode.

Authors:  Gen Liu; Wei Ma; Yan Luo; Deng-Ming Sun; Shuang Shao
Journal:  J Anal Methods Chem       Date:  2014-11-11       Impact factor: 2.193

8.  Xanthine oxidoreductase activity is associated with serum uric acid and glycemic control in hemodialysis patients.

Authors:  Ayumi Nakatani; Shinya Nakatani; Eiji Ishimura; Takayo Murase; Takashi Nakamura; Mari Sakura; Yu Tateishi; Akihiro Tsuda; Masafumi Kurajoh; Katsuhito Mori; Masanori Emoto; Masaaki Inaba
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

9.  Association of the plasma xanthine oxidoreductase activity with the metabolic parameters and vascular complications in patients with type 2 diabetes.

Authors:  Tomoko Okuyama; Jun Shirakawa; Takashi Nakamura; Takayo Murase; Daisuke Miyashita; Ryota Inoue; Mayu Kyohara; Yu Togashi; Yasuo Terauchi
Journal:  Sci Rep       Date:  2021-02-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.